Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|June 7, 2025
Nurr1 modulators - a patent review (2019-present)Markus Egner, Daniel MerkJournal of the American Chemical Society|November 4, 2025
De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI InhibitorsMaxwell Sigal, Markus Egner, Chikako Okada, et al.Journal of Medicinal Chemistry|February 7, 2025
A Nurr1 Agonist Derived from the Natural Ligand DHI Induces Neuroprotective Gene ExpressionMarkus Egner, Romy Busch, Úrsula López-García, et al.Journal of Medicinal Chemistry|November 24, 2025
Structural Tuning of Partial RXR Agonism and AntagonismMax Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.Journal of Medicinal Chemistry|January 23, 2026
Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC DiscoveryMarko Mitrović, Francesco Aleksy Greco, Yiliam Cruz García, et al.Pageof 1